FIELD: medicine.
SUBSTANCE: invention describes crystals of 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine (prasugrel) hydrobromate, comprisions of crystals and pharmaceutical compositions containing them for preventing and treating the diseases associated with thrombus or embolism in an animal.
EFFECT: there are prepared new crystals of prasugrel hydrobromate which possess improved stability and solubility, and can find application in medicine.
13 cl, 7 dwg, 3 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING HIGHLY PURE PRASUGREL OR ACID ADDITION SALT THEREOF | 2007 |
|
RU2424243C2 |
| HYDROPYRIDINE DERIVATIVE ACID ADDITIVE SALTS | 2001 |
|
RU2238275C1 |
| PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2281757C2 |
| PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2270695C2 |
| METHOD FOR PRODUCING HIGH-PURITY PRASUGREL HYDROCHLORIDE | 2008 |
|
RU2435776C2 |
| ASPIRIN-COMPRISING MEDICINAL COMPOSITIONS | 2001 |
|
RU2262933C2 |
| DERIVATIVES OF TETRAHYDROTHIENO-[3,2-C]-PYRIDINE OR THEIR FURO-ANALOGS AND A METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2089553C1 |
| THIENOPYRIDINE ESTER DERIVATIVE, CONTAINING CYANOGROUP, METHOD OF ITS OBTAINING, ITS APPLICATION AND BASED ON IT COMPOSITION | 2011 |
|
RU2526624C2 |
| CRYSTAL COMPOUNDS | 2016 |
|
RU2789672C2 |
| SYNTHESIS OF N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE, AS WELL AS TARTRATE AND CRYSTALLINE FORMS THEREOF | 2005 |
|
RU2417986C2 |
